Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Vaccine
Vaccine
Page 9 of 12
Newsletters
The tech-stock bulls are back
By
Bernhard Warner
September 16, 2020
Health
China’s controversial emergency-use program for COVID vaccines is going global
By
Grady McGregor
September 16, 2020
Newsletters
Is M&A back? Investors hope so, and that’s lifting global stocks
By
Bernhard Warner
September 15, 2020
Newsletters
A flurry of M&A deals lifts global stocks. Yes, even tech stocks
By
Bernhard Warner
September 14, 2020
International
AstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
By
Stephanie Baker
and
Bloomberg
September 13, 2020
Newsletters
The future of the call center
By
David Meyer
and
Alan Murray
September 11, 2020
International
When will a COVID vaccine be ready? The fourth quarter or early 2021, top Chinese vaccine executive says
By
Grady McGregor
September 11, 2020
Health
COVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By
Jeremy Kahn
September 10, 2020
Newsletters
Pfizer’s Albert Bourla: Vaccine efforts are improving Big Pharma’s reputation
By
David Meyer
and
Alan Murray
September 10, 2020
Newsletters
Global markets dip as investors again sour on tech stocks
By
Bernhard Warner
September 10, 2020
International
Scientists see an upside to AstraZeneca halting its COVID-19 vaccine trial
By
Grady McGregor
September 9, 2020
Newsletters
Global stocks climb—and futures jump—after Tuesday’s sell-off
By
Bernhard Warner
September 9, 2020
Newsletters
Why last week’s great tech sell-off should make investors wary
By
Bernhard Warner
September 8, 2020
International
A Chinese vaccine maker is injecting employees and their families with its COVID-19 candidate
By
Grady McGregor
September 7, 2020
Health
Trump wants a COVID-19 vaccine by Election Day. But will one be ready?
By
Jeremy Kahn
September 4, 2020
Most Popular
Big Tech
The Chan Zuckerberg Initiative cut 70 jobs as the Meta CEO’s philanthropy goes all in on mission to 'cure or prevent...
By
Sydney Lake
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez